These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 16106211)

  • 1. Universal leukocyte reduction: Is it appropriate medical practice or not?
    Angelbeck JH; Ortolano GA
    J Infus Nurs; 2005; 28(4):273-81. PubMed ID: 16106211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding leukocyte reduction in blood transfusions.
    Hadaway L
    Nursing; 1999 Oct; 29(10):74. PubMed ID: 10797680
    [No Abstract]   [Full Text] [Related]  

  • 3. What has universal leucodepletion given us: evidence from clinical trials?
    van de Watering L
    Vox Sang; 2004 Jul; 87 Suppl 2():139-42. PubMed ID: 15209899
    [No Abstract]   [Full Text] [Related]  

  • 4. Risk reduction strategies in pediatric blood banking.
    Billman GF
    Pathology (Phila); 1993; 2(1):61-80. PubMed ID: 9420931
    [No Abstract]   [Full Text] [Related]  

  • 5. Leukocyte depletion of red cell units at the bedside by transfusion through a new filter.
    Sirchia G; Rebulla P; Parravicini A; Carnelli V; Gianotti GA; Bertolini F
    Transfusion; 1987; 27(5):402-5. PubMed ID: 3629670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leucodepletion and immune response mechanisms.
    Semple JW
    Vox Sang; 2004 Jul; 87 Suppl 2():136-8. PubMed ID: 15209898
    [No Abstract]   [Full Text] [Related]  

  • 7. Universal WBC reduction: the case for and against.
    Vamvakas EC; Blajchman MA
    Transfusion; 2001 May; 41(5):691-712. PubMed ID: 11346708
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment and prevention of cytomegalovirus in renal transplant patients: weighing the evidence.
    Hakkert A; Dykeman-Sharpe J
    CANNT J; 2003; 13(3):69-73; quiz 74-5. PubMed ID: 14596201
    [No Abstract]   [Full Text] [Related]  

  • 9. To filter blood or universal leukoreduction: what is the answer?
    Shapiro MJ
    Crit Care; 2004; 8 Suppl 2(Suppl 2):S27-30. PubMed ID: 15196319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukocyte-reduction to prevent transfusion-transmitted cytomegalovirus infections.
    Strauss RG
    Pediatr Transplant; 1999; 3 Suppl 1():19-22. PubMed ID: 10587967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Leukocyte depletion and infection by cytomegalovirus].
    Mazeron MC
    Transfus Clin Biol; 2000 Jun; 7 Suppl 1():31s-35s. PubMed ID: 10919221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymerase chain reaction based assessment of leukoreduction efficacy using a cytomegalovirus DNA transfected human T-cell line.
    Lau W; Onizuka R; Krajden M
    J Clin Virol; 1998 Aug; 11(2):109-16. PubMed ID: 9785212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of transfusion-transmitted cytomegalovirus infection.
    Pamphilon DH; Rider JR; Barbara JA; Williamson LM
    Transfus Med; 1999 Jun; 9(2):115-23. PubMed ID: 10354380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transfusion-transmitted cytomegalovirus infection.
    Bowden RA
    Hematol Oncol Clin North Am; 1995 Feb; 9(1):155-66. PubMed ID: 7737939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytomegalovirus infections associated with leukocyte transfusions.
    Winston DJ; Ho WG; Howell CL; Miller MJ; Mickey R; Martin WJ; Lin CH; Gale RP
    Ann Intern Med; 1980 Nov; 93(5):671-5. PubMed ID: 6259981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of cytomegalovirus transmission by blood products to immunocompromised patients and means for reduction.
    Ljungman P
    Br J Haematol; 2004 Apr; 125(2):107-16. PubMed ID: 15059132
    [No Abstract]   [Full Text] [Related]  

  • 17. AABB Committee Report: reducing transfusion-transmitted cytomegalovirus infections.
    ; Heddle NM; Boeckh M; Grossman B; Jacobson J; Kleinman S; Tobian AA; Webert K; Wong EC; Roback JD
    Transfusion; 2016 Jun; 56(6 Pt 2):1581-7. PubMed ID: 26968400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective, randomized clinical trial of universal WBC reduction.
    Dzik WH; Anderson JK; O'Neill EM; Assmann SF; Kalish LA; Stowell CP
    Transfusion; 2002 Sep; 42(9):1114-22. PubMed ID: 12430666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and laboratory precautions that reduce the adverse reactions, alloimmunization, infectivity, and possibly immunomodulation associated with homologous transfusions.
    Wenz B
    Transfus Med Rev; 1990 Oct; 4(4 Suppl 1):3-7. PubMed ID: 1966885
    [No Abstract]   [Full Text] [Related]  

  • 20. Transfusion-transmitted cytomegalovirus infection.
    Bowden RA
    Immunol Invest; 1995; 24(1-2):117-28. PubMed ID: 7713576
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.